HomeCompareIMMB vs XYLD

IMMB vs XYLD: Dividend Comparison 2026

IMMB yields 1000000.00% · XYLD yields 9.02%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMMB wins by $4.7683925249533696e+36M in total portfolio value
10 years
IMMB
IMMB
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full IMMB calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
9.02%
Share price
$38.60
Annual div
$3.48
5Y div CAGR
0.5%
Payout ratio
90%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$2,363.75
Full XYLD calculator →

Portfolio growth — IMMB vs XYLD

📍 IMMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMMBXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMMB + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMMB pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMMB
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$766.32/yr
After 10yr DRIP, annual income (after tax)
$2,009.19/yr
At 15% tax rate, IMMB beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMMB + XYLD for your $10,000?

IMMB: 50%XYLD: 50%
100% XYLD50/50100% IMMB
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMMB buys
0
XYLD buys
0
No recent congressional trades found for IMMB or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMMBXYLD
Forward yield1000000.00%9.02%
Annual dividend / share$2.00$3.48
Payout ratio50%90%
1-year div growth0%-2.1%
5-year div CAGR0%0.5%
Portfolio after 10y$4.7683925249533696e+36M$21.1K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$2,363.75
Total dividends collected$4.7683311610149396e+36M$15.0K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: IMMB vs XYLD ($10,000, DRIP)

YearIMMB PortfolioIMMB Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,626$906.06+$100.00MIMMB
2$934,786,450,701$934,679,439,252.34$11,324$995.47+$934786.44MIMMB
3$8,165,787,108,578,292$8,164,786,887,076,042.00$12,104$1,096.88+$8165787108.57MIMMB
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$12,977$1,212.21+$66665884190957.63MIMMB
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$13,958$1,343.80+$508662171058048128.00MIMMB
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$15,061$1,494.40+$3.62723524842849e+21MIMMB
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$16,307$1,667.30+$2.417368115915061e+25MIMMB
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$17,717$1,866.48+$1.5056740286145463e+29MIMMB
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$19,317$2,096.71+$8.764771002818475e+32MIMMB
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$21,140$2,363.75+$4.7683925249533696e+36MIMMB

IMMB vs XYLD: Complete Analysis 2026

IMMBStock

Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.

Full IMMB Calculator →

XYLDETF

XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs.

Full XYLD Calculator →
📬

Get this IMMB vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMMB vs SCHDIMMB vs JEPIIMMB vs OIMMB vs KOIMMB vs MAINIMMB vs QYLDIMMB vs JEPQIMMB vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.